Together, the results demonstrated that modulation of glucocerebrosidase activity in the CNS of two murine models of PD, independent of the mutation status of Gba1, could affect α-synuclein homeostasis and, in turn, PD progression. This evidence concerns the gene SNCA and Parkinson disease.